Chinese electric vehicle maker Xpeng Motors raised an additional $300 million from investors, including Qatar’s sovereign wealth fund, Qatar Investment Authority.
The Alibaba Group-backed Xpeng had raised around $500 million from Hillhouse, Sequoia Capital China, Aspex, and Coatue in early July.
Last November, Xpeng raised $400 million from investors such as Xiaomi Corp.
The funds would be allocated toward research in areas such as intelligent vehicle technologies.
Xpeng, which has filed for a US initial public offering (IPO), had delivered 19,376 G3 SUVs as of June.
China’s sales of new energy vehicles fell for a 12th straight month in June.
NEVs include battery-powered electric, plug-in petrol-electric hybrid, and hydrogen fuel-cell vehicles.
Investors valued the company at nearly $4 billion.


AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 



